Innovestor Life Science Fund

Innovestor Life Science Fund

Overview

Innovestor Life Science Fund is a venture capital fund that invests in early-stage biotech and digital health companies in the Nordic and Baltic regions.

Year Founded

2022

Portfolio Companies

5

Investments

CompanyDateStageLead
Gesynta Pharma ABJul 2025Series BLead
ActitheraJul 2025Series ACo-investor
Tribune TherapeuticsMar 2025Series ACo-investor
Neumirna TherapeuticsJan 2025Series ACo-investor
Teitur TrophicsMar 2023Series ACo-investor

Key People

Wilhelm Lindholm

CEO, Partner, Partner

Heli Mehtätalo-Takala

Head Of Investor Relations And Communications, Business Advisor, PALO Program

Reima Linnanvirta

Board Member, Member Of Venture Capital Committee, Member Of Tax Committee

Aleksi Huhta

Director, Investor Relations

Hannu Jungman

Partner, Innovestor Ventures

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersHelsinki
Year Founded2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.